DD237658A5 - Verfahren zur herstellung verbesserter entzuendungshemmender salze von piroxicam - Google Patents

Verfahren zur herstellung verbesserter entzuendungshemmender salze von piroxicam Download PDF

Info

Publication number
DD237658A5
DD237658A5 DD85281614A DD28161485A DD237658A5 DD 237658 A5 DD237658 A5 DD 237658A5 DD 85281614 A DD85281614 A DD 85281614A DD 28161485 A DD28161485 A DD 28161485A DD 237658 A5 DD237658 A5 DD 237658A5
Authority
DD
German Democratic Republic
Prior art keywords
piroxicam
salts
reaction
methyl
salt
Prior art date
Application number
DD85281614A
Other languages
German (de)
English (en)
Inventor
Joseph G Lombardino
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD237658A5 publication Critical patent/DD237658A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/672-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02Seven-membered rings
    • C07D313/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/12[b,e]-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DD85281614A 1984-10-11 1985-10-10 Verfahren zur herstellung verbesserter entzuendungshemmender salze von piroxicam DD237658A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/659,733 US4567179A (en) 1984-10-11 1984-10-11 Antiinflammatory salts of piroxicam

Publications (1)

Publication Number Publication Date
DD237658A5 true DD237658A5 (de) 1986-07-23

Family

ID=24646598

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85281614A DD237658A5 (de) 1984-10-11 1985-10-10 Verfahren zur herstellung verbesserter entzuendungshemmender salze von piroxicam

Country Status (25)

Country Link
US (1) US4567179A (ja)
EP (1) EP0178124B1 (ja)
JP (1) JPS6193182A (ja)
KR (1) KR870000277B1 (ja)
CN (1) CN1008062B (ja)
AT (1) ATE44147T1 (ja)
AU (1) AU553819B2 (ja)
CA (1) CA1240323A (ja)
DD (1) DD237658A5 (ja)
DE (1) DE3571132D1 (ja)
DK (1) DK463385A (ja)
EG (1) EG17673A (ja)
FI (1) FI82044C (ja)
GR (1) GR852457B (ja)
HU (1) HU193348B (ja)
IE (1) IE58722B1 (ja)
IL (1) IL76644A0 (ja)
NO (1) NO854033L (ja)
NZ (1) NZ213743A (ja)
PH (1) PH21594A (ja)
PL (1) PL255696A1 (ja)
PT (1) PT81279B (ja)
SU (1) SU1375136A3 (ja)
YU (1) YU44897B (ja)
ZA (1) ZA857785B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4812455A (en) * 1984-10-11 1989-03-14 Pfizer Inc. Antiinflammatory compositions and methods
US5260333A (en) * 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
CA2383252A1 (en) * 1999-08-24 2001-03-01 Medicure International Inc. Treatment of cardiovascular related pathologies
PT1268498E (pt) 2000-02-29 2005-07-29 Medicure Int Inc Fosfonatos cardioprotectores
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
JP2003528146A (ja) 2000-03-28 2003-09-24 メディキュア インターナショナル インコーポレイテッド 脳血管疾患の治療
NZ523815A (en) 2000-07-07 2004-07-30 Medicure Int Inc Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
EP1773370A1 (en) * 2004-07-07 2007-04-18 Medicure International Inc. Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
AU2005304220A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
AU2006317440A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230717A (en) * 1978-12-29 1980-10-28 Lovelace Alan M Administrator Indomethacin-antihistamine combination for gastric ulceration control
US4374843A (en) * 1980-10-14 1983-02-22 Pfizer Inc. 2-Guanidino-4-heteroarylthiazoles
US4434163A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Water-soluble benzothiazine dioxide salts
CY1398A (en) * 1981-09-04 1987-12-18 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
BE894286A (fr) * 1981-09-04 1983-03-02 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)-propyl)amino -1h-1,2,4-triazole-3-methanol ou un sel de ce compose

Also Published As

Publication number Publication date
GR852457B (ja) 1986-02-11
AU4848485A (en) 1986-04-17
CN1008062B (zh) 1990-05-23
PH21594A (en) 1987-12-11
DK463385D0 (da) 1985-10-10
FI853946L (fi) 1986-04-12
HU193348B (en) 1987-09-28
KR870000277B1 (ko) 1987-02-23
NZ213743A (en) 1988-11-29
CN85107498A (zh) 1986-07-02
YU44897B (en) 1991-04-30
FI82044B (fi) 1990-09-28
EP0178124B1 (en) 1989-06-21
JPH0442387B2 (ja) 1992-07-13
KR860003248A (ko) 1986-05-21
IE58722B1 (en) 1993-11-03
PT81279A (en) 1985-11-01
ZA857785B (en) 1987-05-27
ATE44147T1 (de) 1989-07-15
DE3571132D1 (en) 1989-07-27
SU1375136A3 (ru) 1988-02-15
AU553819B2 (en) 1986-07-31
IL76644A0 (en) 1986-02-28
IE852498L (en) 1986-04-11
CA1240323A (en) 1988-08-09
FI82044C (fi) 1991-01-10
DK463385A (da) 1986-04-12
EG17673A (en) 1990-08-30
FI853946A0 (fi) 1985-10-10
PL255696A1 (en) 1986-07-29
NO854033L (no) 1986-04-14
US4567179A (en) 1986-01-28
HUT38539A (en) 1986-06-30
YU161685A (en) 1987-12-31
EP0178124A1 (en) 1986-04-16
JPS6193182A (ja) 1986-05-12
PT81279B (pt) 1988-02-17

Similar Documents

Publication Publication Date Title
DD237658A5 (de) Verfahren zur herstellung verbesserter entzuendungshemmender salze von piroxicam
DE2928485A1 (de) Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
DE2915318A1 (de) Cycloalkyltriazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DD216929A5 (de) Verfahren zur herstellung von thiazolidinderivaten
DD211560A5 (de) Verfahren zur herstellung kristalliner benzothiazindioxid-salze
DE2331246A1 (de) Antiinflammatorisch wirksame thiazolabkoemmlinge und diese enthaltende arzneipraeparate
DE1795792A1 (de) Die serumlipoidkonzentration vermindernde arzneimittel
DD202568A5 (de) Verfahren zur herstellung wasserloeslicher benzothiazindioxid-salze
EP0166183B1 (de) Verwendung von Hydroxyindolderivaten zur Herstellung eines Arzneimittels zur Senkung des Blutdrucks
DE3617976A1 (de) 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
EP0006114A1 (de) 7-Methoxy-5-oxo-5H-thiazolo(2,3-b)chinazolin-2-carbonsäure und deren pharmazeutisch verwendbare Salze. Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
DE3035688C2 (ja)
DE69816520T2 (de) Behandlung von durch Einzeller verursachte Infektionen
EP0030343B1 (de) Substituierte 2-Amino-3,4-dihydropyridinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE1963317A1 (de) Chemische Verfahren und Produkte
DE2654185C2 (de) N-(p-Benzamido)-2-pyrrolidon-4-carbonsäuren und dieselben enthaltende Anti-Ulcusmittel
DE3107594C2 (de) Thiazolylpiperazin-Verbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Immunverstärker
DE3026053C2 (de) 2-substituierte-4-Thiazolidone
DE3105122C2 (de) Neue Piperazin-Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende Immunverstärker
EP0461574A2 (de) 3,7-Diazabicyclo(3,3,1)-nonan-Verbindungen enthaltende Arzneimittel
DE2014847A1 (ja)
DE2844595A1 (de) Acylaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3105121A1 (de) Neue piperazin-verbindungen, verfahren zu ihrer herstellung und ihre verwendung
AT319934B (de) Vzh der neuen 5-n-pyrrylsalicylsaeure und ihrer salze
DE2823266A1 (de) Prophylaktisches oder therapeutisches mittel zur behandlung von allergieerkrankungen und verfahren zu seiner herstellung

Legal Events

Date Code Title Description
NPV Change in the person, the name or the address of the representative (addendum to changes before extension act)
ENJ Ceased due to non-payment of renewal fee